Presentation is loading. Please wait.

Presentation is loading. Please wait.

Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making  Neal Bhutiani, MD, Michael E. Egger, MD,

Similar presentations


Presentation on theme: "Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making  Neal Bhutiani, MD, Michael E. Egger, MD,"— Presentation transcript:

1 Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making  Neal Bhutiani, MD, Michael E. Egger, MD, MPH, Nicolás Ajkay, MD, FACS, Charles R. Scoggins, MD, MBA, FACS, Robert CG. Martin, MD, PhD, FACS, Kelly M. McMasters, MD, PhD, FACS  Journal of the American College of Surgeons  Volume 226, Issue 4, Pages e1 (April 2018) DOI: /j.jamcollsurg Copyright © 2018 American College of Surgeons Terms and Conditions

2 Figure 1 Multigene signature panel (MSP) use over time (2011 to 2014). Use of MSPs increased annually during the study period. Journal of the American College of Surgeons  , e1DOI: ( /j.jamcollsurg ) Copyright © 2018 American College of Surgeons Terms and Conditions

3 Figure 2 Trends in type of multigene signature panel (MSP) used over time (2011 to 2014). Oncotype DX remained the most frequently used MSP during the study period, though the proportional use of MammaPrint increased over time. Journal of the American College of Surgeons  , e1DOI: ( /j.jamcollsurg ) Copyright © 2018 American College of Surgeons Terms and Conditions

4 eFigure 1 Filter strategy for acquisition of study dataset. ER, estrogen receptor; MSP, multigene signature panel. Journal of the American College of Surgeons  , e1DOI: ( /j.jamcollsurg ) Copyright © 2018 American College of Surgeons Terms and Conditions


Download ppt "Multigene Signature Panels and Breast Cancer Therapy: Patterns of Use and Impact on Clinical Decision Making  Neal Bhutiani, MD, Michael E. Egger, MD,"

Similar presentations


Ads by Google